MBX Biosciences Announces Pricing of Initial Public Offering
September 12, 2024 19:11 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 12, 2024 19:00 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
Murano Announces Closing of U.S.$300 Million Offering of Senior Secured Notes
September 12, 2024 18:21 ET
|
Murano Global Investments Plc.
LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- MURANO GLOBAL INVESTMENTS PLC (“Murano” or the “Company”) (NYSE: MRNO), announced today the closing of an offering of U.S.$300,000,000 aggregate principal...
Logan Ridge Finance Corporation Announces the Successful Exit of its Largest Equity Investment, Nth Degree Investment Group, LLC
September 12, 2024 17:47 ET
|
Logan Ridge Finance Corporation
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Logan Ridge Finance Corporation (Nasdaq: LRFC) (the “Company”) today announced that as of September 10, 2024, it has exited its largest equity...
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference
September 12, 2024 17:35 ET
|
Mereo BioPharma Group plc
LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
September 12, 2024 17:30 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Sept. 12, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
September 12, 2024 17:15 ET
|
byNordic Acquisition Corp
New York, NY, Sept. 12, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (NASDAQ: BYNO (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company...
GDEV Announces an At-The-Market Offering
September 12, 2024 17:02 ET
|
GDEV Inc.
GDEV Announces an At-The-Market Offering
Great Elm Capital Corp. Prices Public Offering of $36,000,000 of 8.125% Notes Due 2029
September 12, 2024 17:00 ET
|
Great Elm Capital Corp.
PALM BEACH GARDENS, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today the pricing of its underwritten public offering of...
Great Elm Capital Corp. Announces Conditional Redemption of 6.75% Notes due 2025
September 12, 2024 17:00 ET
|
Great Elm Capital Corp.
PALM BEACH GARDENS, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today that it has caused notices to be issued to the holders...